The early decrease of hepatitis C virus core antigen in the serum of chronic hepatitis C patients predicts drug efficacy and primary response to antiviral therapy

被引:0
|
作者
Coco, B
Moscato, GA
Oliveri, F
Colombatto, P
Ciccorossi, P
Maina, A
Tackney, C
Bonino, F
Brunetto, MR
机构
[1] Azienda Osped Pisana, Hepatol Unit, Pisa, Italy
[2] Osped Maggiore, IRCCS, Milan, Italy
[3] Ortho Clin Diagnost, Raritan, NJ USA
关键词
D O I
10.1016/S0168-8278(02)80368-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
368
引用
收藏
页码:104 / 104
页数:1
相关论文
共 50 条
  • [1] Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay
    Rebucci, C
    Cerino, A
    Cividini, A
    Timo, L
    Furione, M
    Mondelli, MU
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3881 - 3884
  • [2] Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts?
    Mondelli, MU
    JOURNAL OF HEPATOLOGY, 2004, 40 (03) : 536 - 538
  • [3] Early predictive efficacy of core antigen on antiviral outcomes in genotype 1 hepatitis C virus infected patients
    Feng, Bo
    Yang, Rui-Feng
    Zhang, Hai-Ying
    Luo, Bi-Fen
    Kong, Fan-Yun
    Rao, Hui-Ying
    Jin, Qian
    Cong, Xu
    Wei, Lai
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (04): : 390 - 398
  • [4] Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C
    Cividini, A
    Cerino, A
    Muzzi, A
    Furione, M
    Rebucci, C
    Segagni, L
    Gatti, M
    Barnaba, V
    Mondelli, MU
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (05) : 2144 - 2146
  • [5] Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C
    Toyoda, H
    Kumada, T
    Nakano, S
    Takeda, I
    Sugiyama, K
    Kiriyama, S
    Sone, Y
    Miyata, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (03) : 245 - 249
  • [6] Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C
    Grahovac, B
    Bingulac-Popovic, J
    Vucelic, B
    Hrstic, I
    Ostojic, R
    Drazic, V
    Balija, M
    Grgicevic, D
    JOURNAL OF CLINICAL VIROLOGY, 2001, 20 (1-2) : 85 - 89
  • [7] Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy
    Soffredini, R
    Rumi, MG
    Parravicini, ML
    Ronchi, G
    Del Ninno, E
    Russo, A
    Colombo, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1738 - 1743
  • [8] Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C
    Chevaliez, Stephane
    Soulier, Alexandre
    Poiteau, Lila
    Bouvier-Alias, Magali
    Pawlotsky, Jean-Michel
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (01) : 145 - 148
  • [9] The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants
    Yushchuk, N. D.
    Znoyko, O. O.
    Dudina, K. R.
    Kozina, A. N.
    Kalinina, O. V.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (06) : 101 - 105
  • [10] SUCCESSFUL ANTIVIRAL THERAPY IS ASSOCIATED WITH THE DECREASE OF SERUM PROHEPCIDICIN IN CHRONIC HEPATITIS C
    Jaroszewicz, J.
    Rogalska, M.
    Flisiak, R.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S227 - S227